23107-60-0

Upstream product

• 76-83-5 trityl chloride 
• 137-07-5 2-amino-benzenethiol 
• 76-84-6 triphenylmethyl alcohol 

Downstream Products

• 501327-53-3 N-[2-(triphenylmethylthio)phenyl]-2-[(triphenylmethylthio)methylcarbonylamino]ethanamide 
• 341502-37-2 pyridine-2,6-dicarboxylic acid bis-[(2-tritylsulfanyl-phenyl)-amide] 
• 1393845-19-6 C₁₈H₁₇N₅O₂S 
• 1393845-25-4 C₃₇H₃₁N₅O₂S 
• 1393845-17-4 C₃₀H₂₄N₂O₂S 
• 1393845-24-3 C₄₂H₃₄N₂O₃S 
• 223130-58-3 N,N'-bis(2-mercaptophenyl)pyridine-2,6-dicarboxamide 

Relevant academic research and scientific papers

Synthesis and biological evaluation of a new triazole-oxotechnetium complex

A new triazole oxotechnetium chelating agent was synthesized via a 'Click-to-Chelate' strategy. In vivo evaluation of the corresponding 99mTc complex shows that the tracer exhibits very interesting properties for molecular imaging.

Design and synthesis of a novel family of semi-rigid ligands: Versatile compounds for the preparation of 99mTc radiopharmaceuticals

Synthetic pathways to a range of novel semi-rigid tetradentate ligands, with sulfur, amido or amino donor groups, designed to coordinate technetium 99m have been developed. The technetium-99m complexes have been prepared and their stabilities in serum and

A simplified route to the synthesis of new 99mTc-specific tetradentate ligands

The synthesis of two new N2S2 or N2SO tetradentate ligands and the preparation of their technetium-99m complexes are reported. Each ligand leads to a unique 99mTc-complex with an excellent radiochemical yield. T

A synthetic analogue of the active site of Fe-containing nitrile hydratase with carboxamido N and thiolato S as donors: Synthesis, structure, and reactivities

As part of our work on models of the iron(III) site of Fe-containing nitrile hydratase, a designed ligand PyPSH4 with two carboxamide and two thiolate donor groups has been synthesized. Reaction of (Et4N)[FeCl4] with the d

Diagnostic radiopharmaceutical compounds (That)

Tetradentate ligands are used to form neutral 99m-technetium complexes which may be useful as radiopharmaceuticals e.g. as brain imaging agents. The ligands have the structure STR1 where n is 2 or 3, m is 0-4, R is H or substituted or unsubstituted C1 -C6 alkyl, provided that one CR2 group adjacent the starred nitrogen atom represents CO and forms with the adjacent N atom, a --CONH-- amide group, Y is unsubstituted or substituted C1 -C6 alkyl, and one of X and X' represents H or a labile thiol protecting group while the other is unsubstituted or substituted C1 -C6 alkyl, alkenyl or alkynyl.